NMDAR Antibody-associated Auto-immune Encephalitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which NMDAR Antibody-associated Auto-immune Encephalitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT05954468

Psycho-social Impact of Anti-NMDAR Encephalitis

NMDA receptor encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms, but a typically good functional neurological outcome…

France10 participantsStarted 2023-10-09

Treatment: standardized and validated surveys